BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 8763334)

  • 1. P-glycoprotein--a mediator of multidrug resistance in tumour cells.
    Germann UA
    Eur J Cancer; 1996 Jun; 32A(6):927-44. PubMed ID: 8763334
    [No Abstract]   [Full Text] [Related]  

  • 2. Biology of the multidrug resistance-associated protein, MRP.
    Loe DW; Deeley RG; Cole SP
    Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
    [No Abstract]   [Full Text] [Related]  

  • 3. Transporter molecules in multidrug resistance.
    Scheper RJ; Scheffer GL; Flens MJ; van der Valk P; Broxterman HJ; Izquierdo MA
    Cytotechnology; 1996; 19(3):187-90. PubMed ID: 8862005
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro models of multiple drug resistance.
    Greenberger LM; Cohen D; Horwitz SB
    Cancer Treat Res; 1994; 73():69-106. PubMed ID: 7710911
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.
    Germann UA; Shlyakhter D; Mason VS; Zelle RE; Duffy JP; Galullo V; Armistead DM; Saunders JO; Boger J; Harding MW
    Anticancer Drugs; 1997 Feb; 8(2):125-40. PubMed ID: 9073309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein: its role in drug resistance.
    Ling V
    Am J Med; 1995 Dec; 99(6A):31S-34S. PubMed ID: 8585532
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance.
    Twentyman PR; Versantvoort CH
    Eur J Cancer; 1996 Jun; 32A(6):1002-9. PubMed ID: 8763341
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of protein kinase C in multidrug resistance.
    O'Brian CA; Ward NE; Gravitt KR; Fan D
    Cancer Treat Res; 1994; 73():41-55. PubMed ID: 7710909
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetics of the P-glycoprotein, the multidrug transporter.
    Stein WD
    Exp Physiol; 1998 Mar; 83(2):221-32. PubMed ID: 9568482
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanism of action of multidrug-resistance-linked P-glycoprotein.
    Sauna ZE; Smith MM; Müller M; Kerr KM; Ambudkar SV
    J Bioenerg Biomembr; 2001 Dec; 33(6):481-91. PubMed ID: 11804190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological considerations in the modulation of multidrug resistance.
    Fisher GA; Lum BL; Hausdorff J; Sikic BI
    Eur J Cancer; 1996 Jun; 32A(6):1082-8. PubMed ID: 8763350
    [No Abstract]   [Full Text] [Related]  

  • 13. P-glycoprotein and multidrug resistance.
    Gottesman MM; Pastan I; Ambudkar SV
    Curr Opin Genet Dev; 1996 Oct; 6(5):610-7. PubMed ID: 8939727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both P-gp and MRP contribute to drug resistance in AML.
    Legrand O; Simonin G; Zittoun R; Marie JP
    Leukemia; 1998 Aug; 12(8):1327-8. PubMed ID: 9697893
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers.
    Boer R; Gekeler V; Ulrich WR; Zimmermann P; Ise W; Schödl A; Haas S
    Eur J Cancer; 1996 May; 32A(5):857-61. PubMed ID: 9081366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unanswered questions about multidrug resistance.
    Beck WT
    Cytotechnology; 1996; 19(3):177-9. PubMed ID: 8862003
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidrug resistance--a fascinating, clinically relevant problem in bioenergetics.
    Pedersen PL
    J Bioenerg Biomembr; 1995 Feb; 27(1):3-5. PubMed ID: 7629048
    [No Abstract]   [Full Text] [Related]  

  • 18. P-glycoprotein mediated multidrug resistance and its implications for pathology.
    Trambas CM; Muller HK; Woods GM
    Pathology; 1997 May; 29(2):122-30. PubMed ID: 9213329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
    Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
    Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect mechanism of drug transport by P-glycoprotein.
    Roepe PD
    Trends Pharmacol Sci; 1994 Dec; 15(12):445-6. PubMed ID: 7886815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.